TriPRIL CAR T Cells in Multiple Myeloma
Summary
Third Opinion Trial Synopsis:
Scientists are studying a new treatment called TriPRIL CAR T Cells for people with a type of cancer called multiple myeloma. They want to see if it works and if it has any side effects. Participants will also receive two other medicines called Fludarabine and Cyclophosphamide as part of the treatment.
Scientists are studying a new treatment called TriPRIL CAR T Cells for people with a type of cancer called multiple myeloma. They want to see if it works and if it has any side effects. Participants will also receive two other medicines called Fludarabine and Cyclophosphamide as part of the treatment.
*Third Opinion AI Generated Synopsis
Trial Summary
This research study involves the study of TriPRIL CAR T Cells for treating people with relapsed or refractory multiple myeloma and to understand the side effects when treated with TriPRIL CAR T Cells. This research study involves the study drugs:. TriPRIL CAR T Cells Fludarabine and Cyclophosphamide: Standardly used chemotherapy drugs as part of lymphodepleting process
This research study involves the study of TriPRIL CAR T Cells for treating people with relapsed or refractory multiple myeloma and to understand the side effects when treated with TriPRIL CAR T Cells. This research study involves the study drugs:. TriPRIL CAR T Cells Fludarabine and Cyclophosphamide: Standardly used chemotherapy drugs as part of lymphodepleting process
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: